Recruiting
Phase 1
Phase 2

AMPK-activation by Metformin in FSGS: AMP-FSGS

Sponsor:

Yale University

Code:

NCT06090227

Conditions

Focal Segmental Glomerulosclerosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Metformin + Standard of Care

Placebo + Standard of Care

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information